generics
GSK boosts stake in Aspen
May 12, 2009Sales and Marketing GSK, generics
GlaxoSmithKline has extended its stake in the South African generics company Aspen to a 16% shareholding. In return it will …
Biosimilars: time for an approval pathway in the US
March 23, 2009Research and Development, Sales and Marketing US, generics
Congress has received another bill seeking to establish a biosimilars approval pathway in the US. HR 1427 represents the latest …
Biosimilars bill offers 12 years’ marketing exclusivity
March 19, 2009Research and Development US, generics
The US moved one step closer to creating a market for biosimilars – substitutable versions of branded biologic drugs – …
Pfizer expands product deal with Indian generic company
March 5, 2009Sales and Marketing Asia, India, Pfizer, generics
Pfizer has linked up with Indian drug manufacturer Aurobindo Pharma to expand its portfolio of generic medicines in the US …
Sanofi cleared to buy Zentiva
February 11, 2009Sales and Marketing Sanofi, generics
The European Commission says Sanofi-Aventis can go ahead with its planned acquisition of Czech generics company Zentiva. The Commission had …
Teva and Lonza join forces in biosimilars
January 21, 2009Sales and Marketing biosimilars, generics
Teva, the world's largest generics manufacturer, has teamed up with manufacturing specialist Lonza to exploit the market for biosimilar medicines. …
Ratiopharm put up for sale after Merckle suicide
January 19, 2009Sales and Marketing Teva, generics
German generics company Ratiopharm will be sold off following the death Adolf Merckle, its founder and chief executive. Merckle committed …
Preparing for the US generics boom
December 15, 2008Sales and Marketing US, generics
One of Barack Obama's key goals as president is to reduce healthcare costs, particularly those related to prescription medications, by …
Cytotoxic therapies to feel sting of generics
December 8, 2008Sales and Marketing generics
Cytotoxic therapy has been the cornerstone of cancer treatment for many years: indeed, despite a number of unpleasant side effects, …
Latest news from Datamonitor
November 17, 2008Sales and Marketing biosimilars, generics
Key decision makers will shape the biosimilars landscapeWith many biologic drugs used to treat increasingly common diseases such as cancer …
Sanofi seals Zentiva deal with improved offer
September 23, 2008Sales and Marketing MA, Sanofi, generics
Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …
Giuliani to argue Ranbaxy’s case in US
September 18, 2008Sales and Marketing US, generics
Indian generics firm Ranbaxy has hired former New York mayor Rudolf Giuliani to help reverse an FDA block on imports …
Danish court overturns Lipitor patent challenge
September 5, 2008Sales and Marketing Denmark, Lipitor, Pfizer, generics
A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …
Generics giant formed as Teva acquires Barr
July 24, 2008Sales and Marketing generics
Teva is to buy rival firm Barr for $7.5 billion to create a new giant in the global generics industry. …
AstraZeneca wins vital Seroquel battle
July 3, 2008Sales and Marketing AZ, generics, psych
Anglo-Swedish pharma company AstraZeneca has scored a vital victory in defending the patent on its blockbuster drug Seroquel. A US …
Latest content
Five Facts about cardiovascular disease
